Quantcast

Latest Paul Schimmel Stories

2014-07-17 16:25:53

Publication in Science Unveils Novel, Diverse and Separate Biological Functions That Can Be Harnessed Therapeutically to Mediate a Wide Range of Human Disease SAN DIEGO and HONG KONG, July 17, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise, and its subsidiary in Hong Kong, Pangu Biopharma (aTyr), announced the discovery of a new class of human proteins with therapeutic relevance for a wide range of diseases. The findings unveiled today in a...

2014-07-15 00:20:40

SAN DIEGO, July 14, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise announced today, the scientific publication of a splice variant of a tRNA synthetase in association with a rare muscle disease. This article, published in the Journal of Biological Chemistry, demonstrated novel findings relative to Physiocrine proteins, that include extracellular functions derived from the tRNA synthetase gene family. These data further highlight the potential...

2014-05-21 08:29:06

First Demonstration of Safety and Tolerability of Physiocrines SAN DIEGO, May 21, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise, announced today completion of Phase 1 for its lead program, Resokine IV. Our study, which marked the first ever administration of a Physiocrine to humans, was conducted in healthy male and female subjects in the European Union to assess the safety and tolerability of Resokine IV. aTyr Pharma is developing Resokine IV...

2014-03-28 08:26:48

SAN DIEGO, March 28, 2014 /PRNewswire/ -- aTyr Pharma ("aTyr"), a rare disease biotherapeutics enterprise, announced today the appointment of Ed Penhoet, Ph.D., to the Company's board of directors (BOD). Dr. Penhoet, who co-founded Chiron, is an accomplished scientist and biotech pioneer. He has served on the Independent Citizens Oversight Committee (ICOC) for the California Institute of Regenerative Medicine (CIRM) and was recently appointed to President Obama's Council of...

2014-02-24 08:28:17

First Administration to Human Subjects of a New Protein Class, Physiocrines SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- aTyr Pharma, a rare disease therapeutics enterprise, announced today the first administration of Resokine IV to healthy human volunteers. The study is being conducted in healthy male and female volunteers in the European Union. aTyr plans to develop Resokine IV as a potential therapeutic for rare disorders where a patient's immune system is imbalanced. Resokine belongs...

Secret Of Herbal Malaria Cure Unlocked
2012-12-24 11:17:14

redOrbit Staff & Wire Reports - Your Universe Online For over a millennium the Chinese have used an herb known as Chang Shan to treat fevers associated with malaria. While its effectiveness in treating the disease has long been confirmed by modern medicine, its exact function has remained mystery. However, in a recent study, scientists at The Scripps Research Institute (TSRI) say they have uncovered the molecular mechanism that gives this ancient homeopathic drug its healing...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related